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The article Caplacizumab: First Global Approval, written by Sean Duggan, was originally published Online First without open access. After publication in volume 78, issue 15, pages 1639--1642 Ablynx NV requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Ablynx NV. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<http://creativecommons.org/licenses/by-nc/4.0/>), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
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